In a story that blends medical innovation, family resilience, and the power of youthful courage, a nine-year-old boy from Los Angeles has become the youngest stem cell donor in Cedars-Sinai history. His act of bravery is being celebrated not only as a personal triumph for his family but also as a breakthrough moment that underscores the potential of pediatric stem cell donations in the fight against blood cancers.
The journey began in 2022, when Dr. Nick Mondek, a respected anesthesiologist in Los Angeles, was diagnosed with acute myeloid leukemia (AML), a rare and aggressive blood cancer. His first battle with the disease was successfully fought thanks to a stem cell transplant from his younger brother, which placed his illness in remission. But in early 2024, the leukemia returned—stronger, more complex, and with fewer treatment options available.
Despite exhausting every clinical protocol and searching extensively through family members and the National Bone Marrow Registry, no suitable donor emerged. With time running short, hope seemed distant. Yet a question lingered in Mondek’s mind: could his young son Stephen be the answer?
A Bold Decision in the Face of Uncertainty
Medical experts at Cedars-Sinai Cancer, led by Dr. Ronald Paquette, clinical director of the Stem Cell and Bone Marrow Transplant Program, explored the possibility. While Stephen was only nine, and younger than typical donors, his half-match genetic profile carried a unique advantage. A half-match donor can, in some cases, help the body’s immune system more aggressively target and destroy cancerous cells.
“Most transplants rely on perfect matches, but medicine continues to show us that unconventional approaches can sometimes deliver better results,” explained Dr. Paquette. “Stephen’s youth, health, and genetic makeup gave us reason to believe he could provide the exact support his father needed.”
For Dr. Mondek, the most difficult part was asking his child to make such a sacrifice. Yet the conversation with Stephen was surprisingly straightforward. “I told him, ‘Buddy, Dad’s sick, and they need someone to give me stem cells. Would you like to get tested?’ Without hesitation, Stephen simply said, ‘When do we go?’”
The High-Risk Procedure
The process began with weeks of preparation—testing, blood work, and careful counseling. On the day of the procedure, Stephen was admitted to Cedars-Sinai’s pediatric intensive care unit, where a catheter was inserted into his neck vein. For several hours, his blood was drawn, and stem cells were separated and frozen for transplant.
Hospital staff described the procedure as “high risk,” but Stephen remained calm and resolute throughout. His parents watched with equal measures of pride and anxiety. For Stephen, it was an act of love. For his father, it was a chance at life.
A week later, Dr. Mondek began chemotherapy designed to weaken his immune system and prepare his body to receive the transplant. On “transplant day,” Cedars-Sinai staff performed the infusion of Stephen’s stem cells, a moment that Dr. Paquette described as “a rebirth.”
“Every transplant day is dramatic,” Paquette noted. “Patients know they cannot survive without those stem cells, and the delivery is like a second birthday. It marks the beginning of a new immune system.”
A Long Recovery, but Renewed Hope
Following the transplant, Dr. Mondek remained hospitalized for two additional weeks as his team closely monitored whether Stephen’s stem cells would engraft and rebuild his father’s immune defenses. The delicate process required isolation from his family to reduce the risk of infection.
On August 16, after weeks of uncertainty and meticulous observation, Dr. Mondek was discharged, armed with a fragile but hopeful new immune system. Though his battle is far from over, the successful procedure has given the family optimism.
“Everything lined up,” Mondek reflected. “Dr. Paquette said the perfect donor would be someone young, healthy, and a 50% genetic match. We found him right here at home.”
For Stephen, who turned ten shortly after the procedure, the reward was simple yet profound: “I felt good helping my dad,” he said with a smile.
A Story Bigger Than One Family
While the Mondeks’ story is deeply personal, it carries broader implications for the medical community. Pediatric stem cell donations are rare, but this case demonstrates their potential when carefully evaluated and supported by experienced clinical teams.
“This is about more than one patient,” said Dr. Paquette. “It is about showing families and physicians that younger donors, even those previously considered too young, may hold the key to saving lives.”
The case highlights the urgent need for expanding donor registries and considering alternative approaches in the treatment of life-threatening cancers. By pushing beyond traditional boundaries, Cedars-Sinai continues to cement its reputation as a leader in cancer innovation and compassionate care.
The Power of Love and Science
At its core, this story is one of family and courage. A father’s fight for survival intersected with a son’s willingness to step forward, demonstrating how medical science and human love can combine to create miracles. While Dr. Mondek’s journey is ongoing, the transplant represents a turning point filled with hope, gratitude, and resilience.
The Mondeks’ experience serves as a reminder that even in the darkest chapters of life, moments of light and heroism can emerge. Stephen’s bravery will forever stand as a testament to how the youngest among us can inspire and change the world in ways that transcend age.